Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening

Cancer Epidemiology

Volumn 37, Issue 3, 2013, Pages 330-335

  Denters, M J ^a   Deutekom, M ^a   Bossuyt, P M ^a   van Rijn, A F ^a   Fockens, P ^a   Dekker, E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal neoplasia; Fecal immunochemical test (FIT); Mass screening; Participation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CANCER SCREENING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLORECTAL CANCER; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNICITY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PATIENT PARTICIPATION; PILOT STUDY; PRIORITY JOURNAL; SCREENING; SEX DIFFERENCE;

AGE FACTORS; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES;

EID: 84876315900     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.01.007     Document Type: Article

References (28)

1. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348(November (9040)):1472-1477.
2. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348(November (9040)):1467-1471.
3. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993, 328(May (19)):1365-1371.
4. Graser A., Stieber P., Nagel D., Schafer C., Horst D., Becker C.R., et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 2009, 58(February (2)):241-248.
5. Kewenter J., Brevinge H., Engaras B., Haglind E., Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994, 29(May (5)):468-473.
6. Malila N., Hakama M., Pukkala E. A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncol 2007, 46(8):1103-1106.
7. Steele R.J., McClements P.L., Libby G., Black R., Morton C., Birrell J., et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009, 58(April (4)):530-535.
8. Weller D., Coleman D., Robertson R., Butler P., Melia J., Campbell C., et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007, 97(December (12)):1601-1605.
9. Hol L., Wilschut J.A., van B.M., van Vuuren A.J., van d V., Reijerink J.C., et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009, 100(April (7)):1103-1110.
10. van Rossum L.G., van Rijn A.F., Laheij R.J., van Oijen M.G., Fockens P., van Krieken H.H., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135(July (1)):82-90.
11. Faivre J., Dancourt V., Lejeune C., Tazi M.A., Lamour J., Gerard D., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004, 126(June (7)):1674-1680.
12. Denters M.J., Deutekom M., Fockens P., Bossuyt P.M., Dekker E. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterol 2009, 9:28.
13. Nagengast F, Kaandorp C. Follow-up na poliepectomie. Herziene richtlijn. Kwalititeitsinstituut voor de Gezondheidszorg CBO; 2002.
14. Denis B., Ruetsch M., Strentz P., Vogel J.Y., Guth F., Boyaval J.M., et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007, 56(November (11)):1579-1584.
15. Malila N., Oivanen T., Hakama M. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z Gastroenterol 2008, 46(April (Suppl. 1)):S25-S28.
16. Segnan N., Senore C., Andreoni B., Arrigoni A., Bisanti L., Cardelli A., et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005, 97(March (5)):347-357.
17. Cole S.R., Young G.P., Esterman A., Cadd B., Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003, 10(3):117-122.
18. Coughlin S.S., Thompson T.D., Seeff L., Richards T., Stallings F. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Cancer 2002, 95(November (10)):2211-2222.
19. Greiner K.A., James A.S., Born W., Hall S., Engelman K.K., Okuyemi K.S., et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med 2005, 41(August (2)):676-684.
20. Meissner H.I., Breen N., Klabunde C.N., Vernon S.W. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15(February (2)):389-394.
21. Thompson R.S., Michnich M.E., Gray J., Friedlander L., Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care 1986, 24(October (10)):904-914.
22. Young W.F., McGloin J., Zittleman L., West D.R., Westfall J.M. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health 2007, 23(3):238-245.
23. von Euler-Chelpin M., Olsen A.H., Njor S., Jensen A., Vejborg I., Schwartz W., et al. Does educational level determine screening participation?. Eur J Cancer Prev 2008, 17(June (3)):273-278.
24. Bulliard J.L., de Landtsheer J.P., Levi F. Reattendance in the Swiss mammography screening pilot programme. J Med Screen 2004, 11(2):59-64.
25. Lagerlund M., Maxwell A.E., Bastani R., Thurfjell E., Ekbom A., Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening - a population-based register study (Sweden). Cancer Causes Control 2002, 13(February (1)):73-82.
26. van Rijn A.F., van Rossum L.G., Deutekom M., Laheij R.J., Fockens P., Bossuyt P.M., et al. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. J Public Health (Oxf) 2008, 30(December (4)):461-465.
27. Deutekom M., van Rijn A.F., Dekker E., Blaauwgeers H., Stronks K., Fockens P., et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health 2009, 19(August (4)):400-402.
28. McCaffery K., Wardle J., Nadel M., Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen 2002, 9(3):104-108.